Tokyo, Nov. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063579) titled 'A Study of the Feasibility and Acceptability of a Symptom-Reporting App for Patients with Hepatocellular Carcinoma Receiving Immune Checkpoint Inhibitor Therapy' on Nov. 10.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Tokai University
Condition:
Condition - Hepatocellular Carcinoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to evaluate the feasibility, acceptability, and operational challenges of a p...